Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction
Abstract
Background:
Serum soluble AXL (sAXL) and its ligand, Growth Arrest-Specific 6 protein (GAS6), intervene in tissue repair processes. AXL is increased in end-stage heart failure, but the role of GAS6 and sAXL in ST-segment elevation myocardial infarction (STEMI) is unknown.
Objectives:
To study the association of sAXL and GAS6 acutely and six months following STEMI with heart failure and left ventricular remodelling.
Methods:
GAS6 and sAXL were measured by enzyme-linked immunosorbent assay at one day, seven days and six months in 227 STEMI patients and 20 controls. Contrast-enhanced magnetic resonance was performed during admission and at six months to measure infarct size and left ventricular function.
Results:
GAS6, but not sAXL, levels during admission were significantly lower in STEMI than in controls. AXL increased progressively over time (p<0.01), while GAS6 increased only from day 7. GAS6 or sAXL did not correlate with brain natriuretic peptide or infarct size. However, patients with heart failure (Killip >1) had higher values of sAXL at day 1 (48.9±11.9 vs. 44.0±10.7 ng/ml; p<0.05) and at six months (63.3±15.4 vs. 55.9±13.7 ng/ml; p<0.05). GAS6 levels were not different among subjects with heart failure or left ventricular remodelling. By multivariate analysis including infarct size, Killip class and sAXL at seven days, only the last two were independent predictors of left ventricular remodelling (odds ratio 2.24 (95% confidence interval: 1.08–4.63) and odds ratio 1.04 (95% confidence interval: 1.00–1.08) respectively).
Conclusion:
sAXL levels increased following STEMI. Patients with heart failure and left ventricular remodelling have higher sAXL levels acutely and at six month follow-up. These findings suggest a potential role of the GAS6–AXL system in the pathophysiology of left ventricular remodelling following STEMI.
Get full access to this article
View all access and purchase options for this article.
References
1. Moran AE, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: The Global Burden of Disease 2010 study. Circulation 2014; 129(14): 1483–1492.
2. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002; 106: 2351–2357.
3. Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 2014; 11: 255–265.
4. Shinde AV, Frangogiannis NG. Fibroblasts in myocardial infarction: A role in inflammation and repair. J Mol Cell Cardiol 2014; 70: 74–82.
5. Altara R, Manca M, Sabra R, et al. Temporal cardiac remodeling post-myocardial infarction: Dynamics and prognostic implications in personalized medicine. Heart Fail Rev 2015; 21: 25–47.
6. Frangogiannis NG. Activation of the innate immune system in the pathogenesis of acute heart failure. Eur Hear J Acute Cardiovasc Care. Epub ahead of print 1 April 2017.
7. Maskrey BH, Megson IL, Whitfield PD, et al. Mechanisms of resolution of inflammation: A focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 2011; 31: 1001–1006.
8. Seropian IM, Sonnino C, van Tassell BW, et al. Inflammatory markers in ST-elevation acute myocardial infarction. Eur Hear J Acute Cardiovasc Care 2016; 5: 382–395.
9. Seropian IM, Toldo S, van Tassell BW, et al. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol 2014; 63: 1593–1603.
10. Van der Meer JHM, van der Poll T, van’t Veer C. TAM receptors, Gas6, and protein S: Roles in inflammation and hemostasis. Blood 2014; 123: 2460–2469.
11. Camenisch TD, Koller BH, Earp HS, et al. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol 1999; 162: 3498–3503.
12. Choi J-Y, Seo JY, Yoon Y-S, et al. Mer signaling increases the abundance of the transcription factor LXR to promote the resolution of acute sterile inflammation. Sci Signal 2015; 8: ra21.
13. Lemke G, Burstyn-Cohen T. TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci 2010; 1209: 23–29.
14. Wan E, Yeap XY, Dehn S, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res 2013; 113: 1004–1012.
15. Rothlin C V, Carrera-Silva EA, Bosurgi L, et al. TAM receptor signaling in immune homeostasis. Annu Rev Immunol 2015; 33: 355–391.
16. Ekman C, Stenhoff J, Dahlbäck B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010; 8: 838–844.
17. Batlle M, Recarte-Pelz P, Roig E, et al. AXL receptor tyrosine kinase is increased in patients with heart failure. Int J Cardiol 2014; 173: 402–409.
18. Garcia-Alvarez A, Sitges M, Delgado V, et al. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol 2009; 104: 878–882.
19. Ortiz-Pérez JT, Lee DC, Meyers SN, et al. Determinants of myocardial salvage during acute myocardial infarction. JACC Cardiovasc Imaging 2010; 3: 491–500.
20. Ortiz-Pérez JT, Riera M, Bosch X, et al. Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: A prospective controlled study. PLoS One 2013; 8: e61695.
21. Perea RJ, Morales-Ruiz M, Ortiz-Perez JT, et al. Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping. Int J Cardiol 2016; 223: 458–464.
22. Alciato F, Sainaghi PP, Castello L, et al. Development and Validation of an ELISA method for detection of growth arrest specific 6 (gas6) protein in human plasma. J Immunoassay Immunochem 2008; 29: 167–180.
23. Recarte-Pelz P, Tàssies D, Espinosa G, et al. Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: Correlation with common genetic variants and disease activity. Arthritis Res Ther 2013; 15: R41.
24. Howangyin K-Y, Zlatanova I, Pinto C, et al. Myeloid-epithelial-reproductive receptor tyrosine kinase and milk fat globule epidermal growth factor 8 co-ordinately improve remodeling after myocardial infarction via local delivery of vascular endothelial growth factor. Circulation 2016; 133: 826–839.
25. Zizzo G, Hilliard BA, Monestier M, et al. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 2012; 189: 3508–3520.
26. Fernández-Fernández L, Bellido-Martín L, García de, Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 2008; 100: 604–610.
27. Laurance S, Lemarié CA, Blostein MD. Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr 2012; 3: 196–203.
28. Jin C, Wang H, Chen Y, et al. Gas6 delays senescence in vascular smooth muscle cells through the PI3K/Akt/FoxO signaling pathway. Cell Physiol Biochem 2015; 35: 1151–1166.
29. Korshunov VA, Mohan AM, Georger MA, et al. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 2006; 98: 1446–1452.
30. Clauser S, Meilhac O, Bièche I, et al. Increased secretion of gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost 2012; 107: 140–149.
31. Alciato F, Sainaghi PP, Sola D, et al. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol 2010; 87: 869–875.
32. Hung YJ, Lee CH, Chu NF, et al. Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 2010; 33: 1840–1844.
33. Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 2006; 98: 1024–1031.
34. Son B-K, Akishita M, Iijima K, et al. Mechanism of pi-induced vascular calcification. J Atheroscler Thromb 2008; 15: 63–68.
35. Collett G, Wood A, Alexander MY, et al. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res 2003; 92: 1123–1129.
36. Borgel D, Durand E, Clauser S, et al. Plasma Gas6 levels and coronary artery disease. Thromb Haemost 2009; 101: 215–216.
37. Lee C-H, Shieh Y-S, Tsai C-S, et al. Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting. PLoS One 2013; 8: e79452.
38. Jiang L, Liu CY, Yang QF, et al. Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am J Clin Pathol 2009; 131: 738–743.
39. Liu Y-W, Yang Q-F, Zuo P-Y, et al. Elevated serum levels of soluble Axl in acute coronary syndrome. Am J Med Sci 2015; 349: 124–129.
40. Stanton LW, Garrard LJ, Damm D, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res 2000; 86: 939–945.
41. Ortiz-Pérez JT, Riera M, Bosch X, et al. Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: A prospective controlled study. PLoS One 2013; 8: e61695.
42. Batlle M, Campos B, Farrero M, et al. Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP. Int J Cardiol 2016; 225: 113–119.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: November 9, 2017
Issue published: December 2019
Keywords
PubMed: 29119801
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in European Heart Journal: Acute Cardiovascular Care.
View All Journal MetricsArticle usage*
Total views and downloads: 222
*Article usage tracking started in December 2016
Altmetric
See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 20 view articles Opens in new tab
Crossref: 18
- Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regula...
- m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translati...
- Pterostilbene protects against H 2 O ...
- Plasma GAS6 predicts mortality risk in acute heart failure patients: i...
- Prognostic Value of Soluble AXL in Serum from Heart Failure Patients w...
- Prognostic value of plasma sAXL in patients with heart failure: insigh...
- Serum Gas6 contributes to clinical outcome after aneurysmal subarachno...
- Electrochemical immunosensing of Growth arrest‐specific 6 in human pla...
- Potential diagnostic and prognostic of efferocytosis-related unwanted ...
- Definition of left ventricular remodelling following ST-elevation myoc...
- Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Se...
- Microvesicles in plasma reflect coronary flow reserve in patients with...
- Macrophage AXL receptor tyrosine kinase inflames the heart after reper...
- Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncolo...
- MerTK Expression and ERK Activation Are Essential for the Functional M...
- The Effect of Five-Day Dry Immersion on the Nervous and Metabolic Mech...
- Reflection of Heart Rate Physiological Regulation Parameters in the Ur...
- TAM receptors in cardiovascular disease
Figures and tables
Figures & Media
Tables
Get access
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
I am signed in as:
View my profileSign out
I can access personal subscriptions, purchases, paired institutional access and free tools such as favourite journals, email alerts and saved searches.
Access journal content via a university, library or employer subscription.
ESC members and conference delegates can access this journal content using society membership credentials.
There is currently no price available for this item in your region.
Access journal content via a DeepDyve subscription or find out more about this option.
